This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.




2gpl

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2gpl.gif|left|200px]]
+
{{Seed}}
 +
[[Image:2gpl.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2gpl| PDB=2gpl | SCENE= }}
{{STRUCTURE_2gpl| PDB=2gpl | SCENE= }}
-
'''TMC-95 based biphenyl-ether macrocycles: specific proteasome inhibitors'''
+
===TMC-95 based biphenyl-ether macrocycles: specific proteasome inhibitors===
-
==Overview==
+
<!--
-
TMC-95's natural cyclic tripeptide metabolites represent potent competitive proteasome inhibitors. The constrained conformation of TMC-95 proteasomal inhibitors provides the driving force for entropically high-affinity binding. Based on the crystal structure of the proteasome:TMC-95A complex, the synthetically challenging TMC-95 core structure was used for the design and synthesis of less demanding biphenyl-ether macrocycles, in which the biphenyl-ether moiety functions as an endocyclic clamp restricting its tripeptide backbone. These simplified analogs allowed us to identify high plasticity of the proteasomal tryptic-like specificity pocket. Biphenyl-ether compounds extended with an amide group were hydrolyzed by the proteasome, although the crystal structure of such proteasome:biphenyl-ether complexes revealed quenching of proteolysis at the acyl-enzyme intermediate. Our data reveal that biphenyl-ether derivatives bind noncovalently to the proteasomal tryptic-like active site in a reversible substrate-like manner without allosteric changes of active site residues.
+
The line below this paragraph, {{ABSTRACT_PUBMED_16793518}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 16793518 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_16793518}}
==About this Structure==
==About this Structure==
Line 30: Line 34:
[[Category: Ntn-hydrolase]]
[[Category: Ntn-hydrolase]]
[[Category: Proteasomal subunit fold represents an antiparallel beta-sheet flanked by helice]]
[[Category: Proteasomal subunit fold represents an antiparallel beta-sheet flanked by helice]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 05:22:24 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 20:53:02 2008''

Revision as of 17:53, 27 July 2008

Image:2gpl.png

Template:STRUCTURE 2gpl

TMC-95 based biphenyl-ether macrocycles: specific proteasome inhibitors

Template:ABSTRACT PUBMED 16793518

About this Structure

2GPL is a Protein complex structure of sequences from Saccharomyces cerevisiae. Full crystallographic information is available from OCA.

Reference

TMC-95-based inhibitor design provides evidence for the catalytic versatility of the proteasome., Groll M, Gotz M, Kaiser M, Weyher E, Moroder L, Chem Biol. 2006 Jun;13(6):607-14. PMID:16793518

Page seeded by OCA on Sun Jul 27 20:53:02 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2gpl"
Personal tools